Cukrová, V.; Neuwirtová, R.; Doležalová, L.; Beličková, M.; Bartůňková, J.; Jonášová, A.; Čermák, J.; Homolková, H.; Malíková, I.

Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome

[rok vydání 2009, impact factor 3.106]

Neupauerová, J.; Vraná, M.; Ratajová, E.; Nazarová, S.; Půbalová, Š.; Šálek, C.; Crivello, P.; Březinová, J.; Beličková, M.; Dyr, J.E.

The formation of a somatic mutation in the HLA-B gene throughout the development of the disease from severe aplastic anaemia to acute myeloid leukaemia

[rok vydání 2019, impact factor 2.955 ]

Krejcik, Z.; Belickova, M.; Hrustincova, A.; Votavova, H.; Jonasova, A.; Cermak, J.; Dyr, J.E.; Merkerova, M.D.

MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia

[rok vydání 2018, impact factor 2.859 ]

Valka, J.; Vesela, J.; Votavova, H.; Dostalova-Merkerova, M.; Horakova, Z.; Campr, V.; Brezinova, J.; Zemanova, Z.; Jonasova, A.; Cermak, J.; Belickova, M.

Differential expression of homologous recombination DNA repair genes in the early and advanced stages of myelodysplastic syndrome

[rok vydání 2017, impact factor 2.595 ]

Vasikova, A.; Belickova, M.; Budinska, E.; Cermak, J.

A distinct expression of various gene subsets in CD34+ cells from patients with early and advanced myelodysplastic syndrome

[rok vydání 2010, impact factor 2.555]

Dostalova Merkerova, M.; Krejcik, Z.; Belickova, M.; Hrustincova, A.; Klema, J.; Stara, E.; Zemanova, Z.; Michalova, K.; Cermak, J.; Jonasova, A.

Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide

[rok vydání 2014, impact factor 2.544 ]

Svobodova, K.; Zemanova, Z.; Lhotska, H.; Podskalska, L.; Belickova, M.; Brezinova, J.; Sarova, I.; Izakova, S.; Lizcova, L.; Berkova, A.; Siskova, M.; Jonasova, A.; Cermak, J.; Michalova, K.

Copy number neutral loss of heterozygosity (CN-LOH) 17p and homozygous mutations of TP53 gene are associated with complex chromosomal aberrations (CCA) in newly diagnosed myelodysplastic syndromes (MDS)

[rok vydání 2015, impact factor 2.501 ]

Neuwirtova, R.; Fuchs, O.; Holicka, M.; Vostry, M.; Kostecka, A.; Hajkova, H.; Jonasova, A.; Cermak, J.; Cmejla, R.; Pospisilova, D.; Belickova, M.; Siskova, M.; Hochova, I.; Vondrakova, J.; Sponerova, D.; Kadlckova, E.; Novakova, L.; Brezinova, J.; Michalova, K.

Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemia

[rok vydání 2012, impact factor 2.396 ]

Veselovska, J.; Pospisilova, D.; Pekova, S.; Horvathova, M.; Solna, R.; Cmejlova, J.; Cmejla, R.; Belickova, M.; Mihal, V.; Stary, J.; Divoky, V.

Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro, with rare JAK2 V617F-positive erythroid colonies

[rok vydání 2008, impact factor 2.390]

Čermák, J.; Beličková, M.; Krejčová, H.; Michalová, K.; Žilovcová, S.; Zemanová, Z.; Březinová, J.; Sieglová, Z.

The presence of clonal cell populations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.

[rok vydání 2006, impact factor 2.372]

Krejčík, Z.; Beličková, M.; Hruštincová, A.; Kléma, J.; Zemanová, Z.; Michalová, K.; Čermák, J.; Jonášová, A.; Dostálová Merkerová, M.

Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment

[rok vydání 2015, impact factor 2.333 ]

Merkerova, M.; Belickova, M.; Bruchova, H.

Differential expression of microRNAs in hematopoietic cell lineages

[rok vydání 2008, impact factor 2.237]

Jonasova, A.; Neuwirtova, R.; Polackova, H.; Siskova, M.; Stopka, T.; Cmunt, E.; Belickova, M.; Moudra, A.; Minarik, L.; Fuchs, O.; Michalova, K.; Zemanova, Z.

Lenalidomide treatment in lower risk myelodysplastic syndromes: the experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients)

[rok vydání 2018, impact factor 2.066 ]

Valka, J.; Vesela, J.; Votavova, H.; Dostalova-Merkerova, M.; Urbanova, Z.; Jonasova, A.; Cermak, J.; Belickova, M.

Genetic variant screening of DNA repair genes in myelodysplastic syndrome identifies a novel mutation in the XRCC2 gene

[rok vydání 2019, impact factor 1.967 ]

Dostalova Merkerova, M.; Hrustincova, A.; Krejcik, Z.; Votavova, H.; Ratajova, E.; Cermak, J.; Belickova, M.

Microarray profiling defines circulating microRNAs associated with myelodysplastic syndromes

[rok vydání 2017, impact factor 1.696 ]

Belickova, M.; Cermak, J.; Dostalova Merkerova, M.; Vesela, J.; Krejcik, Z.; Cechova, E.; Zemanova, Z.; Michalova, K.; Votavova, H.; Caniga, M.; Neuwirtova, R.; Jonasova, A.

Changes associated with lenalidomide treatment in the gene expression profiles of patients with del(5q)

[rok vydání 2012, impact factor 1.667 ]

Belickova, M.; Dostalova Merkerova, M.; Votavova, H.; Valka, J.; Vesela, J.; Pejsova, B.; Hajkova, H.; Klema, J.; Cermak, J.; Jonasova, A.

Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms

[rok vydání 2016, impact factor 1.610 ]

Cechova, H.; Lassuthova, P.; Novakova, L.; Belickova, M.; Stemberkova, R.; Jencik, J.; Stankova, M.; Hrabakova, P.; Pegova, K.; Zizkova, H.; Cermak, J.

Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia

[rok vydání 2012, impact factor 1.574 ]

Vasikova, A.; Budinska, E.; Belickova, M.; Cermak, J.; Bruchova, H.

Differential gene expression of bone marrow CD34+ cells in early and advanced myelodysplastic syndrome

[rok vydání 2009, impact factor 1.192]

Beličková, M.; Bruchová, H.; Cajthamlová, H.; Hrkal, Z.; Brdička, R.

Genes involved in the destruction of leukaemic cells by induced photosensitivity

[rok vydání 2006, impact factor 0.351]